 | • レポートコード：QYR9ST02296 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の細菌性膣炎薬市場について調査・分析し、以下の構成でお届け致します。細菌性膣炎薬の種類別には、経口、局所に、用途別には、骨盤内炎症性疾患、乳児早産、尿路感染、性感染症（STD）に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別細菌性膣炎薬売上データ ・地域別細菌性膣炎薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別細菌性膣炎薬市場規模：経口、局所 ・用途別細菌性膣炎薬市場規模：骨盤内炎症性疾患、乳児早産、尿路感染、性感染症（STD） ・主要メーカーの企業情報：Bayer、Pfizer、Sanofi、Starpharma Holdings ・細菌性膣炎薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Bacterial vaginosis is an imbalance of “good” and “bad” bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women’s health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.
The global Bacterial Vaginosis Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bacterial Vaginosis Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Bacterial Vaginosis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bacterial Vaginosis Drugs in these regions.
This research report categorizes the global Bacterial Vaginosis Drugs market by top players/brands, region, type and end user. This report also studies the global Bacterial Vaginosis Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Pfizer
Sanofi
Starpharma Holdings
Market size by Product
Oral
Topical
Market size by End User
Pelvic Inflammatory Disease
Preterm Delivery of Infants
Urinary Tract Infection
Sexually Transmitted Diseases (STD)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Bacterial Vaginosis Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bacterial Vaginosis Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bacterial Vaginosis Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bacterial Vaginosis Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Bacterial Vaginosis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bacterial Vaginosis Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Bacterial Vaginosis Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by Product
1.4.2 Oral
1.4.3 Topical
1.5 Market by End User
1.5.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by End User
1.5.2 Pelvic Inflammatory Disease
1.5.3 Preterm Delivery of Infants
1.5.4 Urinary Tract Infection
1.5.5 Sexually Transmitted Diseases (STD)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bacterial Vaginosis Drugs Market Size
2.1.1 Global Bacterial Vaginosis Drugs Revenue 2014-2025
2.1.2 Global Bacterial Vaginosis Drugs Sales 2014-2025
2.2 Bacterial Vaginosis Drugs Growth Rate by Regions
2.2.1 Global Bacterial Vaginosis Drugs Sales by Regions
2.2.2 Global Bacterial Vaginosis Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Bacterial Vaginosis Drugs Sales by Manufacturers
3.1.1 Bacterial Vaginosis Drugs Sales by Manufacturers
3.1.2 Bacterial Vaginosis Drugs Sales Market Share by Manufacturers
3.1.3 Global Bacterial Vaginosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Bacterial Vaginosis Drugs Revenue by Manufacturers
3.2.1 Bacterial Vaginosis Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Bacterial Vaginosis Drugs Price by Manufacturers
3.4 Bacterial Vaginosis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Bacterial Vaginosis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bacterial Vaginosis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Bacterial Vaginosis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Bacterial Vaginosis Drugs Sales by Product
4.2 Global Bacterial Vaginosis Drugs Revenue by Product
4.3 Bacterial Vaginosis Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Bacterial Vaginosis Drugs Breakdown Data by End User
6 North America
6.1 North America Bacterial Vaginosis Drugs by Countries
6.1.1 North America Bacterial Vaginosis Drugs Sales by Countries
6.1.2 North America Bacterial Vaginosis Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Bacterial Vaginosis Drugs by Product
6.3 North America Bacterial Vaginosis Drugs by End User
7 Europe
7.1 Europe Bacterial Vaginosis Drugs by Countries
7.1.1 Europe Bacterial Vaginosis Drugs Sales by Countries
7.1.2 Europe Bacterial Vaginosis Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bacterial Vaginosis Drugs by Product
7.3 Europe Bacterial Vaginosis Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Bacterial Vaginosis Drugs by Countries
8.1.1 Asia Pacific Bacterial Vaginosis Drugs Sales by Countries
8.1.2 Asia Pacific Bacterial Vaginosis Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Bacterial Vaginosis Drugs by Product
8.3 Asia Pacific Bacterial Vaginosis Drugs by End User
9 Central & South America
9.1 Central & South America Bacterial Vaginosis Drugs by Countries
9.1.1 Central & South America Bacterial Vaginosis Drugs Sales by Countries
9.1.2 Central & South America Bacterial Vaginosis Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Bacterial Vaginosis Drugs by Product
9.3 Central & South America Bacterial Vaginosis Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Bacterial Vaginosis Drugs by Countries
10.1.1 Middle East and Africa Bacterial Vaginosis Drugs Sales by Countries
10.1.2 Middle East and Africa Bacterial Vaginosis Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Bacterial Vaginosis Drugs by Product
10.3 Middle East and Africa Bacterial Vaginosis Drugs by End User
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Business Overview
11.1.3 Bayer Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer Bacterial Vaginosis Drugs Products Offered
11.1.5 Bayer Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Bacterial Vaginosis Drugs Products Offered
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Bacterial Vaginosis Drugs Products Offered
11.3.5 Sanofi Recent Development
11.4 Starpharma Holdings
11.4.1 Starpharma Holdings Company Details
11.4.2 Company Business Overview
11.4.3 Starpharma Holdings Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Starpharma Holdings Bacterial Vaginosis Drugs Products Offered
11.4.5 Starpharma Holdings Recent Development
12 Future Forecast
12.1 Bacterial Vaginosis Drugs Market Forecast by Regions
12.1.1 Global Bacterial Vaginosis Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Regions 2019-2025
12.2 Bacterial Vaginosis Drugs Market Forecast by Product
12.2.1 Global Bacterial Vaginosis Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Product 2019-2025
12.3 Bacterial Vaginosis Drugs Market Forecast by End User
12.4 North America Bacterial Vaginosis Drugs Forecast
12.5 Europe Bacterial Vaginosis Drugs Forecast
12.6 Asia Pacific Bacterial Vaginosis Drugs Forecast
12.7 Central & South America Bacterial Vaginosis Drugs Forecast
12.8 Middle East and Africa Bacterial Vaginosis Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bacterial Vaginosis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Bacterial Vaginosis Drugs Product Picture
Table Bacterial Vaginosis Drugs Market Segments
Table Key Manufacturers Bacterial Vaginosis Drugs Covered
Table Global Bacterial Vaginosis Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Bacterial Vaginosis Drugs Sales Market Share by Product 2014-2025
Figure Oral Product Picture
Table Major Manufacturers of Oral
Figure Topical Product Picture
Table Major Manufacturers of Topical
Table Global Bacterial Vaginosis Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Pelvic Inflammatory Disease
Figure Preterm Delivery of Infants
Figure Urinary Tract Infection
Figure Sexually Transmitted Diseases (STD)
Figure Bacterial Vaginosis Drugs Report Years Considered
Figure Global Bacterial Vaginosis Drugs Market Size 2014-2025 (Million US$)
Figure Global Bacterial Vaginosis Drugs Sales 2014-2025 (K MT)
Table Global Bacterial Vaginosis Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Bacterial Vaginosis Drugs Sales by Regions 2014-2019 (K MT)
Table Global Bacterial Vaginosis Drugs Sales Market Share by Regions 2014-2019
Figure Global Bacterial Vaginosis Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Bacterial Vaginosis Drugs Sales Market Share by Regions
Table Global Bacterial Vaginosis Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Bacterial Vaginosis Drugs Revenue Market Share by Regions 2014-2019
Figure Global Bacterial Vaginosis Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Bacterial Vaginosis Drugs Revenue Market Share by Regions
Table Global Bacterial Vaginosis Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Bacterial Vaginosis Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Bacterial Vaginosis Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Bacterial Vaginosis Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2014-2019)
Figure Bacterial Vaginosis Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Bacterial Vaginosis Drugs Price (2014-2019) (USD/MT)
Table Bacterial Vaginosis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Bacterial Vaginosis Drugs Product Type
Table Date of International Manufacturers Enter into Bacterial Vaginosis Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Bacterial Vaginosis Drugs Sales by Product (2014-2019) (K MT)
Table Global Bacterial Vaginosis Drugs Sales Share by Product (2014-2019)
Figure Global Bacterial Vaginosis Drugs Sales Market Share by Product (2014-2019)
Figure Global Bacterial Vaginosis Drugs Sales Market Share by Product in 2018
Table Global Bacterial Vaginosis Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Bacterial Vaginosis Drugs Revenue Share by Product (2014-2019)
Figure Global Bacterial Vaginosis Drugs Revenue Market Share by Product (2014-2019)
Figure Global Bacterial Vaginosis Drugs Revenue Market Share by Product in 2018
Table Bacterial Vaginosis Drugs Price by Product 2014-2019 (USD/MT)
Table Global Bacterial Vaginosis Drugs Sales by End User (2014-2019) (K MT)
Table Global Bacterial Vaginosis Drugs Sales Share by End User (2014-2019)
Figure Global Sales Bacterial Vaginosis Drugs Market Share by End User (2014-2019)
Figure Global Sales Bacterial Vaginosis Drugs Market Share by End User in 2018
Figure North America Bacterial Vaginosis Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Bacterial Vaginosis Drugs Sales by Countries (2014-2019) (K MT)
Table North America Bacterial Vaginosis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Bacterial Vaginosis Drugs Sales Market Share by Countries
Table North America Bacterial Vaginosis Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Bacterial Vaginosis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Bacterial Vaginosis Drugs Revenue Market Share by Countries
Figure United States Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Bacterial Vaginosis Drugs Sales by Product (2014-2019) (K MT)
Table North America Bacterial Vaginosis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Bacterial Vaginosis Drugs Market Share by Product
Table North America Bacterial Vaginosis Drugs Sales by End User (2014-2019) (K MT)
Table North America Bacterial Vaginosis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Bacterial Vaginosis Drugs Market Share by End User
Figure Europe Bacterial Vaginosis Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Bacterial Vaginosis Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Bacterial Vaginosis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Bacterial Vaginosis Drugs Sales Market Share by Countries
Table Europe Bacterial Vaginosis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Bacterial Vaginosis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Bacterial Vaginosis Drugs Revenue Market Share by Countries
Figure Germany Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Bacterial Vaginosis Drugs Sales by Product (2014-2019) (K MT)
Table Europe Bacterial Vaginosis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Bacterial Vaginosis Drugs Market Share by Product
Table Europe Bacterial Vaginosis Drugs Sales by End User (2014-2019) (K MT)
Table Europe Bacterial Vaginosis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Bacterial Vaginosis Drugs Market Share by End User
Figure Asia Pacific Bacterial Vaginosis Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Bacterial Vaginosis Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Countries
Table Asia Pacific Bacterial Vaginosis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Bacterial Vaginosis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Bacterial Vaginosis Drugs Revenue Market Share by Countries
Figure China Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Bacterial Vaginosis Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Bacterial Vaginosis Drugs Market Share by Product
Table Asia Pacific Bacterial Vaginosis Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Bacterial Vaginosis Drugs Market Share by End User
Figure Central & South America Bacterial Vaginosis Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Bacterial Vaginosis Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Bacterial Vaginosis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Bacterial Vaginosis Drugs Sales Market Share by Countries
Table Central & South America Bacterial Vaginosis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Bacterial Vaginosis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Bacterial Vaginosis Drugs Revenue Market Share by Countries
Figure Brazil Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Bacterial Vaginosis Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Bacterial Vaginosis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Bacterial Vaginosis Drugs Market Share by Product
Table Central & South America Bacterial Vaginosis Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Bacterial Vaginosis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Bacterial Vaginosis Drugs Market Share by End User
Figure Middle East and Africa Bacterial Vaginosis Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Bacterial Vaginosis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Bacterial Vaginosis Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Countries
Table Middle East and Africa Bacterial Vaginosis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Bacterial Vaginosis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Bacterial Vaginosis Drugs Revenue Market Share by Countries
Figure GCC Countries Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Bacterial Vaginosis Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Bacterial Vaginosis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Bacterial Vaginosis Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Bacterial Vaginosis Drugs Market Share by Product
Table Middle East and Africa Bacterial Vaginosis Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Bacterial Vaginosis Drugs Market Share by End User
Table Bayer Company Details
Table Bayer Bacterial Vaginosis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Pfizer Company Details
Table Pfizer Bacterial Vaginosis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Bacterial Vaginosis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Starpharma Holdings Company Details
Table Starpharma Holdings Bacterial Vaginosis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Starpharma Holdings Recent Development
Table Global Bacterial Vaginosis Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Bacterial Vaginosis Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Bacterial Vaginosis Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Bacterial Vaginosis Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Bacterial Vaginosis Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Bacterial Vaginosis Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Bacterial Vaginosis Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Bacterial Vaginosis Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Bacterial Vaginosis Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Bacterial Vaginosis Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Bacterial Vaginosis Drugs Value Chain
Table Bacterial Vaginosis Drugs Customers List
Table Bacterial Vaginosis Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
細菌性結膜炎薬の世界市場：インサイト・予測 Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …- 世界の細菌性眼感染症治療薬市場：専門的調査 It is a serious eye infection caused by several types of bacteria. The global Bacterial Eye Infection Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Bacterial Eye Infection …
- 泌尿生殖器薬の世界市場：インサイト・予測 A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pi…
- 炎症性腸疾患薬の世界市場：インサイト・予測 Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. The growth in prevalence of inflammatory bowel diseases such as ulcerative …
- 世界の膣炎薬市場：専門的調査 Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. The global Vaginosis Drug market was valued at xx million US$ in 2018 and will reach xx million US$ …